Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 6 de 6
1.
J Nutr ; 154(2): 610-616, 2024 02.
Article En | MEDLINE | ID: mdl-38072151

BACKGROUND: A common neonatal intensive care unit (NICU) discharge feeding strategy for preterm infants with growth failure who are fed exclusively expressed human milk (EHM) has been to enrich mother's own milk with formula powder or supplement 2-3 feeds per day with formula. However, this strategy displaces human milk from the diet. Our NICU recently adopted the standard practice of adding commercial human milk fortifier (HMF) to human milk feedings after discharge. OBJECTIVES: We aimed to compare breastfeeding rates and growth using the aforementioned 2 strategies. METHODS: Preterm infants (<34 wk of gestation at birth) exclusively feeding EHM fortified with HMF at 2 weeks before discharge were included in this retrospective study. The HMF group (n = 92) continued fortifying with HMF at home, whereas the historical comparison group (n = 35) received our previous guidance to enrich or supplement using postdischarge formula. RESULTS: Rates of human milk exclusivity after discharge decreased significantly less in the HMF group than those in the historical comparison group (to 83% compared with 39% at the first outpatient visit and 27% compared with 6%, respectively, at the second outpatient visit). Rates of any EHM feedings were also significantly higher in the HMF group. Fenton z-scores for weight, length, and head circumference were not significantly different between the groups. CONCLUSIONS: Continuing EHM fortification with HMF after NICU discharge, rather than enriching or supplementing with postdischarge infant formula, increases rates of feeding EHM for ≥3 mo but does not affect growth.


Infant, Premature , Milk, Human , Infant , Humans , Infant, Newborn , Intensive Care Units, Neonatal , Patient Discharge , Retrospective Studies , Aftercare , Weight Gain , Infant, Very Low Birth Weight , Food, Fortified
2.
Breastfeed Med ; 18(8): 571-578, 2023 08.
Article En | MEDLINE | ID: mdl-37615564

Introduction: Mothers of preterm infants are at risk for inadequate milk production. Pumping logs are often used to both encourage lactation in the first week and track its efficacy. Our objectives were to determine whether mothers of preterm infants who keep pumping logs are demographically different from those who do not and to determine whether this practice affects the amount of mother's own milk (MOM) fed to their infants. We also aimed at determining whether there is a correlation between: (1) time to first breast milk expression, (2) cumulative frequency of expression in the first week, and (3) milk volume on day 7 with subsequent milk volumes and percent of infant diet consisting of MOM. Methods: Mothers of infants born ≤32 weeks and ≤1,500 g were enrolled within 48 hours of birth and encouraged to keep a pumping log. Data were collected on maternal characteristics, patterns of milk expression, and milk volumes on days 7, 14, 21, and 28 after delivery. Infant data were collected via chart review. Results: Mothers who kept pumping logs provided their own milk for a greater percentage of their infant's feeds at the time of achieving full feeds (p = 0.017). The total number of expressions in the first week was correlated with milk volume on day 21 (p = 0.016) and the provision of a higher percentage of MOM feeds at discharge (p = 0.03). Milk volume on day 7 correlated with volumes obtained at days 14, 21, and 28 (p < 0.001). Conclusions: Pumping logs may affect the availability of MOM for preterm infants. Frequency of pumping in the first week and milk volume on day 7 may impact long-term lactation success for these women.


Milk, Human , Mothers , Infant, Newborn , Infant , Female , Humans , Infant, Premature , Breast Feeding , Breast
3.
J Matern Fetal Neonatal Med ; 34(19): 3220-3226, 2021 Oct.
Article En | MEDLINE | ID: mdl-31736368

BACKGROUND: Airway dysbiosis in premature infants may be associated with bronchopulmonary dysplasia (BPD). Early oropharyngeal colostrum (OPC) administration alters the oral microbiome, which may impact the lung microbiome. We aim to compare the oral and tracheal microbiota during the first week of life, and to determine whether early OPC administration affects microbial diversity or leukocyte inflammatory activity in the lung. METHODS: Intubated premature infants (n = 42) were evaluated. The oral microbiome was characterized on day of life (DOL) 3, and the tracheal microbiome on DOL 3 and DOL 7, using 16S ribosomal DNA sequencing. Gene expression for inflammatory markers was quantified in airway leukocytes by real-time q-PCR. RESULTS: The oral and tracheal microbiota were significantly different on DOL 3, but the tracheal microbiome on DOL 7 was more similar to the oral from DOL 3. Tracheal bacterial diversity decreased from DOL 3 to DOL 7. Longer time to first OPC administration tended to be associated with lower bacterial diversity in the airways. CONCLUSIONS: The tracheal microbiome in intubated premature infants in the first week is likely determined, in part, by the composition of the oral microbiome. Bacterial diversity in intubated babies decreases during the first week of life, a pattern that could be consistent with risk for BPD. Decreased bacterial diversity and increased inflammatory activity in the lung may also be associated with delayed administration of OPC.


Bronchopulmonary Dysplasia , Microbiota , Dysbiosis , Humans , Infant , Infant, Newborn , Infant, Premature , Lung
4.
J Perinatol ; 40(2): 284-287, 2020 02.
Article En | MEDLINE | ID: mdl-31748654

BACKGROUND: Early administration of colostrum may provide preterm infants with immune components. Previous studies illustrating the effects of oral colostrum (OC) have been confounded by the coincidence of enteral feedings. OBJECTIVE: To quantify OC absorption, as measured by urinary sIgA and lactoferrin, in preterm infants prior to enteral feedings. MATERIALS AND METHODS: Colostrum was obtained from mothers delivering infants ≤32 weeks and ≤1500 g. sIgA and lactoferrin were measured in infant urine, and microflora in saliva and tracheal aspirates were characterized. RESULTS: Urinary sIgA and lactoferrin were significantly greater in infants receiving OC by syringe compared to swab (p < 0.002). Urinary sIgA correlated with the total number of doses in 72 h (R2 = 43%, p < 0.01). CONCLUSIONS: Administration of OC by syringe and higher cumulative dose are associated with increased absorption of sIgA and lactoferrin, and early dosing may contribute to a more diverse tracheal microbiome.


Colostrum/immunology , Immunoglobulin A, Secretory/urine , Infant, Premature/immunology , Infant, Very Low Birth Weight/immunology , Lactoferrin/urine , Administration, Oral , Analysis of Variance , Humans , Infant, Newborn , Infant, Premature/urine , Microbiota , Mouth/microbiology , Mouth Mucosa , Pilot Projects , Trachea/microbiology
5.
Semin Perinatol ; 41(1): 36-40, 2017 02.
Article En | MEDLINE | ID: mdl-27836421

Human milk is the preferred diet for preterm infants as it protects against a multitude of NICU challenges, specifically necrotizing enterocolitis. Infants who receive greater than 50% of mother's own milk (MOM) in the 2 weeks after birth have a significantly decreased risk of NEC. An additional factor in the recent declining rates of NEC is the increased utilization of donor human milk (DHM). This creates a bridge until MOM is readily available, thus decreasing the exposure to cow milk protein. Preterm infants are susceptible to NEC due to the immaturity of their gastrointestinal and immune systems. An exclusive human milk diet compensates for these immature systems in many ways such as lowering gastric pH, enhancing intestinal motility, decreasing epithelial permeability, and altering the composition of bacterial flora. Ideally, preterm infants should be fed human milk and avoid bovine protein. A diet consisting of human milk-based human milk fortifier is one way to provide the additional nutritional supplements necessary for adequate growth while receiving the protective benefits of a human milk diet.


Breast Feeding , Enterocolitis, Necrotizing/diet therapy , Enterocolitis, Necrotizing/prevention & control , Gastrointestinal Microbiome/immunology , Infant, Premature, Diseases/diet therapy , Infant, Premature, Diseases/prevention & control , Milk, Human/microbiology , Animals , Enterocolitis, Necrotizing/physiopathology , Humans , Infant Nutritional Physiological Phenomena , Infant, Extremely Premature , Infant, Newborn , Infant, Premature, Diseases/physiopathology , Infant, Very Low Birth Weight , Milk , Milk, Human/immunology , Probiotics
6.
J Arthroplasty ; 26(8): 1396-403, 2011 Dec.
Article En | MEDLINE | ID: mdl-21353454

We retrospectively analyzed 97 total knee arthroplasty cases with medial osteoarthritis from seven participating surgeons in our teaching hospital to determine the percentage of patients who met the following eligibility criteria for unicompartmental knee arthroplasty (UKA): healthy cartilage in the lateral compartment based on (1) visual analysis, (2) histological analysis and (3) absence of UKA contraindications based on clinical analysis. The cases with healthy lateral cartilage, intact anterior cruciate ligament and posterior cruciate ligament, lack of patello-femoral arthritis, preoperative range of motion (ROM) greater than 90, and genu varum less than 10° represented 21% of the 97 cases studied. This percentage would likely have been higher had the cases been assessed earlier in the disease process. It was concluded that there is the potential to utilize UKA more frequently in the future.


Arthroplasty, Replacement, Knee/instrumentation , Arthroplasty, Replacement, Knee/methods , Knee Joint/pathology , Knee Joint/surgery , Knee Prosthesis , Osteoarthritis, Knee/surgery , Prosthesis Design , Adult , Aged , Aged, 80 and over , Anterior Cruciate Ligament/pathology , Anterior Cruciate Ligament/surgery , Eligibility Determination , Female , Femur/pathology , Femur/surgery , Humans , Knee Joint/physiology , Male , Middle Aged , Osteoarthritis, Knee/pathology , Posterior Cruciate Ligament/pathology , Posterior Cruciate Ligament/surgery , Range of Motion, Articular/physiology , Retrospective Studies , Treatment Outcome
...